292 related articles for article (PubMed ID: 25646297)
1. Denervation of the renal arteries in metabolic syndrome: the DREAMS-study.
Verloop WL; Spiering W; Vink EE; Beeftink MM; Blankestijn PJ; Doevendans PA; Voskuil M
Hypertension; 2015 Apr; 65(4):751-7. PubMed ID: 25646297
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
[TBL] [Abstract][Full Text] [Related]
3. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
[TBL] [Abstract][Full Text] [Related]
4. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.
Mahfoud F; Schlaich M; Kindermann I; Ukena C; Cremers B; Brandt MC; Hoppe UC; Vonend O; Rump LC; Sobotka PA; Krum H; Esler M; Böhm M
Circulation; 2011 May; 123(18):1940-6. PubMed ID: 21518978
[TBL] [Abstract][Full Text] [Related]
5. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
[TBL] [Abstract][Full Text] [Related]
6. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension.
Hering D; Lambert EA; Marusic P; Walton AS; Krum H; Lambert GW; Esler MD; Schlaich MP
Hypertension; 2013 Feb; 61(2):457-64. PubMed ID: 23172929
[TBL] [Abstract][Full Text] [Related]
7. Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome.
Tsioufis C; Dimitriadis K; Kasiakogias A; Kalos T; Liatakis I; Koutra E; Nikolopoulou L; Kordalis A; Ella RO; Lau EO; Grassi G; Papademetriou V; Tousoulis D
J Hypertens; 2017 May; 35(5):1100-1108. PubMed ID: 28106665
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
[TBL] [Abstract][Full Text] [Related]
9. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
Tsioufis C; Papademetriou V; Tsiachris D; Kasiakogias A; Kordalis A; Thomopoulos C; Dimitriadis K; Tousoulis D; Stefanadis C; Parati G; Worthley S
Int J Cardiol; 2015 Feb; 180():237-42. PubMed ID: 25463375
[TBL] [Abstract][Full Text] [Related]
10. Effects of renal denervation on end organ damage in hypertensive patients.
Verloop WL; Vink EE; Spiering W; Blankestijn PJ; Doevendans PA; Bots ML; Vonken EJ; Voskuil M; Leiner T
Eur J Prev Cardiol; 2015 May; 22(5):558-67. PubMed ID: 25326543
[TBL] [Abstract][Full Text] [Related]
11. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M
Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects two years after renal denervation in insulin resistant hypertensive patients. The Re-Shape CV-risk study.
Miroslawska AK; Gjessing PF; Solbu MD; Norvik JV; Fuskevåg OM; Hanssen TA; Steigen TK
Clin Nutr; 2021 Apr; 40(4):1503-1509. PubMed ID: 33743285
[TBL] [Abstract][Full Text] [Related]
13. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
Witkowski A; Prejbisz A; Florczak E; Kądziela J; Śliwiński P; Bieleń P; Michałowska I; Kabat M; Warchoł E; Januszewicz M; Narkiewicz K; Somers VK; Sobotka PA; Januszewicz A
Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482
[TBL] [Abstract][Full Text] [Related]
14. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
[TBL] [Abstract][Full Text] [Related]
15. Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension.
Lambert T; Blessberger H; Gammer V; Nahler A; Grund M; Kerschner K; Buchmayr G; Saleh K; Kammler J; Steinwender C
Clin Cardiol; 2014 May; 37(5):307-11. PubMed ID: 24700288
[TBL] [Abstract][Full Text] [Related]
16. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Duval J; Lee R; Sata Y; Krum H; Lambert E; Peter K; Head G; Lambert G; Esler MD; Schlaich MP
Int J Cardiol; 2016 Jan; 202():388-93. PubMed ID: 26432488
[TBL] [Abstract][Full Text] [Related]
17. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
[TBL] [Abstract][Full Text] [Related]
18. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
[TBL] [Abstract][Full Text] [Related]
19. Renal sympathetic denervation induces changes in heart rate variability and is associated with a lower sympathetic tone.
Hoogerwaard AF; de Jong MR; Adiyaman A; Smit JJJ; Delnoy PPHM; Heeg JE; van Hasselt BAAM; Ramdat Misier AR; Rienstra M; van Gelder IC; Elvan A
Clin Res Cardiol; 2019 Jan; 108(1):22-30. PubMed ID: 29943270
[TBL] [Abstract][Full Text] [Related]
20. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.
Rosa J; Widimský P; Waldauf P; Lambert L; Zelinka T; Táborský M; Branny M; Toušek P; Petrák O; Čurila K; Bednář F; Holaj R; Štrauch B; Václavík J; Nykl I; Krátká Z; Kociánová E; Jiravský O; Rappová G; Indra T; Widimský J
Hypertension; 2016 Feb; 67(2):397-403. PubMed ID: 26693818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
